The Biotechnology And Pharmaceutical Industry Essay

QUALIFICATIONS PROFILE Detail-oriented and independent scientist, pursuing a senior scientist role in the biotechnology and pharmaceutical industry to fully utilize well-honed expertise in biochemistry, molecular and cellular biology techniques ï‚ § Hands-on and supervisory experience in molecular cloning, genome editing, protein expression, cell line generation and characterization, and cell-based assay developments ï‚ § Strong analytical and problem-solving skills, as well as the ability to motivate high-caliber teams of professionals to achieve high levels of productivity CORE COMPETENCIES ï‚ § Molecular and Cellular Biology: Mammalian Cell Culture (Stem Cells, Primary Neurons, and Neuronal Differentiation) | CRISPR-mediated Genome Editing | si/shRNA-mediated Gene Knockdown | Immunohistochemistry | Molecular Cloning and Library Construction | Fluorescence in situ Hybridization (FISH) | Lentivirus | Yeast Two-Hybrid Screening ï‚ § Biochemistry: ELISA | Western Blot Analysis | Immunoprecipitation | Protein Expression (E.coli, yeast, and mammalian cells) | Protein Purification | Protein Characterization (Protein-Protein Interaction, Posttranslational Modification, and Co-localization) | Enzyme Kinetics | ï‚ § Analytical Techniques: Confocal Microscopy | Flow Cytometry | Quantitative RT-PCR | Spectrometry | HPLC | LC/GC-MS | Statistical Analysis (R, GraphPad PRIZM) | Genomics and Proteomics Data Analysis (R/Bioconductor, Genome Browser, Gene Ontology, and Ingenuity Pathway Analysis)Show MoreRelatedCynthia Robbins-Roth and the Biotechnology Industry614 Words   |  3 PagesCynthia Robbins-Roth is a strategic planner and business consultant to the biotechnology industry, named one of the Top 25 Biotech All-Stars by popular business magazine Forbes. Her book, published in year 2000, provides a broad overview of many biotech topics and draws upon her experience and skill as a keen businesswoman. The engaging and informative work initially details the establishment and growth of the biotechnology industry, as well as its historical origins and information on key players in itsRead MoreEssay about The New Trade Theory1326 Words   |  6 Pagesa large scale of output† as it is abl e to spread over the fixed costs over a large volume of quantity (Wickramasekera, Cronk Hill 2013 p90). â€Å"First-mover advantages are the economic and strategic advantages that accrue to early entrants into an industry and the ability to capture scale economies ahead of later entrants† (Wickramasekera, Cronk Hill 2013 p91). The new trade theory however, is not free from criticism. Although the theory has achieved great success academically, there is little toRead MoreBiotechnology Industry Analysis1121 Words   |  5 PagesBiotechnology  industry Analysis BACKGROUND The health care industry Provides health products and service which involved the leading technology of life science. It is a fast-growing industry and will continue to grow in the future because of the increasing request to the advanced medical care. The Global Industry Analysis (GIA,2009) predicted that the prescription drug market is value around $897 billion in world economy in 2015, and Asia-Pacific region is expected to have highest growth in prescriptionRead MoreThe Biotechnology Innovation Organization Defines The Biotech Industry906 Words   |  4 Pages The Biotechnology Innovation Organization defines the biotech industry as, â€Å"technology based on biology - biotechnology harnesses cellular and bio-molecular processes to develop technologies and products that help improve our lives and the health of our planet.† This Vital sector of the free market is comprised of many great companies. The five choices that I have selected are, in my opinion, the best choices to represent the biotechnology industry. My first choice was AbbVie Inc., or (ABBV),Read MoreBuyer Bargain Power Of The Pharmaceutical Industry1377 Words   |  6 PagesBuyer Bargain Power Buyers in the pharmaceutical industry are broken into physicians, who are the prescribers, patients, who are the users, hospital boards, who are authorizers of purchases and treatments, pharmacists, who are the distributors. Most of them have very minor influence on the pricing of the product, but unfortunately for the highly regulated pharmaceutical industry, they have to face a bargaining giants, the health organizations and the government agencies. Individual patients haveRead MoreThreat Of New Entrants : Low848 Words   |  4 PagesThreat of New Entrants: Low The barrier to enter Biotechnology industry is high. The first barrier is the extensive requirements in funding coming from heavy expenditures in RD, along with the risk of little to no returns or even heavy losses if the drug fails to reach the market. Regulatory environment partly contributes to the barrier as the new drug approval process can be time-consuming with relatively 89% of failure to pass through. The second barrier is specialization. Companies with knowledgeRead MoreThe Patent Law Of Taiwan1269 Words   |  6 Pageseffective date of the TRIPS agreement, 25 developing countries excluded pharmaceutical products from patent protection. Pharmaceutical companies who own blockbuster patent drugs unquestionably played an influential role in expediting the birth of the TRIPS agreement. The strong protection accorded by patent law allows pharmaceutical companies to charge high price for patented drugs. To seek protection in another country, the Pharmaceutical Research and Manuf acturers’ Association (PhRMA) is involved in heavyRead MoreBiotechnology in Malysia : Medicinal Patent Essay1161 Words   |  5 PagesIn Malaysia, pharmaceutical inventions in the form of products or process can be protected as patents upon meeting the patentability requirement and do not fall under statutory exceptions for non-patentable subject matters. The requirements for patentability of pharmaceutical inventions are that the invention must be new, involves an inventive step and it is industrially applicable. According to Biotechnology In Malaysia (2008), granted patents in the healthcare field are showing an increasing trendRead MoreKey Challenges and Opportunities Essay904 Words   |  4 PagesKey Challenges Opportunities: Big Pharma Bio tech The pharmaceutical industry has shown remarkable structural stability as majority of its key players have been in existence for almost a century now. However, it has not been an exception to unpredictable times of the 21st century as it is grappling with quite a number of challenges. The most urgent issues include termination of manufacturers’ rights, importation risks, pricing problems and the infiltration of counterfeit drugs, the cost of RDRead MoreSanofi Aventis Swot Analysis1750 Words   |  7 Pagesclimate change. Changes in temperature can impact on many industries including farming, tourism and insurance ;legal, the set of rules that the company must comply (tax regulations, commercial, social ...). In this way PESTEL provides a better understanding of the macro-environment factors ; furthermore this analysis helps the company in strategic planning and decision. 2. Sanofi Aventis Description and Background Sanofi, a French pharmaceutical group created in 1973. It is chaired by Serge Weinberg